Analyst Ratings for Gilead Sciences (GILD)
GILD Rating Summary
GILD Price Target Summary
- Highest: $180.00 (Jefferies)
- Lowest: $120.00 (RBC Capital)
- Average: $157.70
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$157.70 (+17.4%)
* Over Last 12-Mos
Rating Score: 8.4 / 10
Percentile Rank: 86%
Avg. $ Target:
$157.70 (+17.4%)
* Over Last 12-Mos
Rating Score: 8.4 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/1/2026 | HSBC | Rajesh Kumar | Upgrade | Buy (Hold) |
155.00 (133.00) |
125.97 (134.28) |
6.6% | Details |
| 5/20/2026 | Maxim Group | Michael Okunewitch | Upgrade | Buy (Hold) |
165.00 (N/A) |
130.50 (134.28) |
2.9% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


